0000899243-19-002640.txt : 20190205 0000899243-19-002640.hdr.sgml : 20190205 20190205165502 ACCESSION NUMBER: 0000899243-19-002640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171130 FILED AS OF DATE: 20190205 DATE AS OF CHANGE: 20190205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibbs Michael Terrence CENTRAL INDEX KEY: 0001665000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 19568646 MAIL ADDRESS: STREET 1: 12 STONEY BROOK RD. CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-30 0 0001492674 T2 Biosystems, Inc. TTOO 0001665000 Gibbs Michael Terrence 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 General Counsel Common Stock 2017-11-30 4 M 0 6500 A 50687 D Common Stock 2018-11-30 4 M 0 6500 A 57187 D Common Stock 2019-01-31 4 S 0 939 3.35 D 56248 D Common Stock 2019-02-01 4 S 0 1820 3.47 D 54428 D Restricted Stock Units 2017-11-30 4 M 0 6500 0.00 D Common Stock 6500 0 D Restricted Stock Units 2018-11-30 4 M 0 6500 0.00 D Common Stock 6500 0 D Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock. Includes 1,220 shares acquired under the Issuer's employee stock purchase plan on November 15, 2018. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.32 to $3.39. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.34 to $3.55. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On November 30, 2016 the reporting person was granted 13,000 RSU's that vested in two equal annual installments beginning on November 30, 2017. /s/ John Sprague, Attorney-in-fact 2019-02-05